Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 20 Medical Startup Investors in New Zealand in April 2025

Last updated: Apr 2025 A list of 20 angel investors and VC (Venture Capital) funds that invest in Medical startups based in New zealand. We rank investors based on the number of investments they made in Medical companies from New zealand. We update this investor list every month.

Top 20 Medical Startup Investors in New Zealand in April 2025

Investor	Medical New Zealand investments
Icehouse Ventures	3
Enterprise Angels	2
IP Group	2
Matū Fund	2
Pacific Channel	2
Auckland UniServices	1
K1W1	1
New Zealand Growth Capital Partners	1
New Zealand Venture Investment Fund	1
Global from Day One	1
Flying Kiwi Angels	1
Hostplus	1
Novaquest Capital Management	1
Cure Kids Ventures	1
Novartis Venture Fund	1
Uniservices	1
ArcAngels	1
AngelHQ	1
Movac	1
GD1	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.

Investment focus

Software, SaaS, Information Technology
Seed, Series A, Funding Round
New Zealand, United States, United Kingdom

Portfolio highlights

Marama Labs — Marama Labs provides an integrated chemical analysis platform that empowers customers to optimize their production processes and match their products and brands to customer needs, with ease.
Watchful — Watchful operates as an AI security company.
Crimson Education — Crimson Education is the world's leading higher educational consultancy helping students around the world gain admission into leading US and UK universities by up to 400%!

Connecting startup business owners with angel investors to raise capital . Access a network of expertise and investment opportunities.

Investment focus

Software, Information Technology, Health Care
Funding Round, Seed, Angel
New Zealand, United States, United Kingdom

Portfolio highlights

Emerge — Emerge is a financial management tool for businesses. It is a digital-only banking option designed to help Kiwi businesses operate more quickly, economically, and efficiently.
Yabble — Yabble provides a platform that uses machine learning and natural language processing to help brands connect with more than 62 million consumers globally, and collect data in real-time. Using the solution, clients can build their own surveys and manage their own customer research communities.
Zenno Astronautics — Zenno Astronautics hardware and software products ensure satellite missions are effectively managed, guaranteeing maximum economic returns and responsible use of space.

IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

Investment focus

Health Care, Biotechnology, Therapeutics
Seed, Series A, Series B
United Kingdom, United States, Australia

Portfolio highlights

Diffblue — Diffblue Cover uses next generation autonomous AI to automate unit testing so that Java development teams can build better applications faster
Microbiotica — Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. The company's therapeutics identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to phenotype before testing of candidate bacteria in advanced human in vitro and invivo models.
Alesi Surgical — Developer of Ultravision, the revolutionary system that clears surgical smoke from the visual field during laparoscopic surgery

Investing in scalable science and deep tech start-ups in Aotearoa NZ. We operate venture capital funds that invest in science and deep tech through a hands-on, active approach.

Investment focus

Biotechnology, Robotics, Nanotechnology
Seed
New Zealand, United States

Portfolio highlights

Ligar — Providing molecular filtration solutions to companies in the food, beverage, health, therapeutics, flavour and aroma industries. Our unique MIP and Polymer technology enables companies to improve their products and operational processes by extracting, reducing or concentrating flavours or compounds.
Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
PowerON — Dielectric Elastomers for Soft Robotics

Investing in great people solving hard problems to create a better future.

Investment focus

Medical Device, Medical, Information Technology
Seed, Series A
New Zealand, Australia

Portfolio highlights

Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
Conry Tech — Conry Tech is a climate tech company, reinventing air-conditioning to decarbonise and improve comfort, founded by renowned HVAC industry revolutionising experts.
Green Gravity — Green Gravity is an electric power generation company that enables renewable energy transition using energy storage technology.

At UniServices, we partner with the University of Auckland to transform ideas into real-world solutions that impact globally.

Investment focus

Medical, Marketing, Health Care
Seed, Pre-Seed
New Zealand

Portfolio highlights

eVouch — eVouch is the most powerful marketing tool we've used to build an organic community. We've experienced elevated brand trust while reaching an audience we never thought possible. Using customers to market to their friends is simply genius.
Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.

K1W1 provides startups and businesses in New Zealand with early and later-stage venture investments.

Investment focus

Software, Artificial Intelligence, Biotechnology
Seed, Series A, Funding Round
New Zealand, United States

Portfolio highlights

Auror — The platform for retailers focused on improving safety, productivity, and profitability. Auror is used by leading Loss Prevention teams in thousands of stores.
Emerge — Emerge is a financial management tool for businesses. It is a digital-only banking option designed to help Kiwi businesses operate more quickly, economically, and efficiently.
Zenno Astronautics — Zenno Astronautics hardware and software products ensure satellite missions are effectively managed, guaranteeing maximum economic returns and responsible use of space.

The New Zealand Growth Capital Partners (formerly New Zealand Venture Investment Fund) was established to support early-stage technology companies and to stimulate private investment into this space.

Investment focus

Software, SaaS, Information Technology
Seed, Series A, Funding Round
New Zealand, United States

Portfolio highlights

Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
Marama Labs — Marama Labs provides an integrated chemical analysis platform that empowers customers to optimize their production processes and match their products and brands to customer needs, with ease.
Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.

Your guide to finding and using government services.

Investment focus

Software, Biotechnology, SaaS
Seed, Series A, Angel
New Zealand, United States, Japan

Portfolio highlights

Insite AI — We create predictability for consumer brands in the unpredictable world of retail. Game-changing technology that attacks consumer brands' hardest problems.
Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.
Surgical Design Studios — The Insides Company is the leading provider of chyme reinfusion solutions for intestinal failure

GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.

Investment focus

Software, SaaS, Medical Device
Seed, Series A, Funding Round
New Zealand, United States, China

Portfolio highlights

eVouch — eVouch is the most powerful marketing tool we've used to build an organic community. We've experienced elevated brand trust while reaching an audience we never thought possible. Using customers to market to their friends is simply genius.
Flowingly — Unlock Team Productivity. Streamline Approvals. Increase Compliance. Easy To Use, No-Code Process Mapping & Workflow Automation Platform.
Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.

Flying Kiwi Angels ? Helping Kiwi Startups

Investment focus

Software, Information Technology, Apps
Seed, Angel, Pre-Seed
New Zealand

Portfolio highlights

FileInvite — The simplest, most secure, document collection platform for professionals. Request files, forms, data and e-signatures all through a secure client portal.
Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
Kara Technologies — Content accessibility using a signing avatar. Accessible solutions are at the core of all that we do here at Kara. One of our main goals is finding smarter ways of using technology that will help build a better future for everyone, in all areas of life.

Join our leading Australian superannuation fund, committed to putting our members first, with a low admin fee and strong returns. Become a member today!

Investment focus

Software, Biotechnology, Renewable Energy
Series A, Series B, Series C
Australia, United Kingdom, United States

Portfolio highlights

Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
Sonder — One app. One go-to. One support system.Sonder is the trusted wellbeing partner for some of the world’s most innovative organisations as they reimagine how to care and support their people.With a clear purpose of breaking down barriers to help, providing the right support to people at the right time. Acknowledging that there are often multiplefactors at play, and wellbeing comprises of cultural, social, environmental and vocational factors, all which play a part in getting to the root cause of issues, and on a path to wellness.The heart of Sonder's solution is a technology-driven platform supported in real time by medical and mental health experts - experts that are available every minute of every day. Their mission is to get the right outcome across any wellbeing or safety issue.Trusted by major corporations, education providers and Government to enhance wellbeing across the world, Sonder is on a mission to create a better world, accepting differences and supportive of others. A world where it's OK to ask for help, for anything, at any time of the day or night.It takes humans to help other humans. That’s why Sonder combines a human first, tech supported approach.
Cardiac Dimensions — Cardiac Dimensions, Inc. is a medical device company developing novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. Our product, the Carillon® Mitral Contour System®, is a groundbreaking, non-surgical device developed to treat functional mitral valve regurgitation. Our system uses acatheter based approach to reshape the mitral valve and reduce mitral regurgitation.

About NovaQuest Capital provides strategic capital to life science and healthcare companies. With experience managing over $2.75 billion of investor capital across multiple asset classes, the firm provides a robust life sciences and healthcare platform focused on promoting the development and gro...

Investment focus

Biotechnology, Health Care, Pharmaceutical
Private Equity, Series A, Post-IPO Equity
United States, New Zealand, United Kingdom

Portfolio highlights

Mirna — Mirna is a veterinary diagnostics company that specializes in the development of veterinary disease testing technology.
Hansa Biopharma — We are dedicated to developing lifesaving and life-altering treatments that can empower patients affected by rare immunologic conditions to live longer and healthier lives.
Phathom Pharmaceuticals — A late clinical-stage biopharmaceutical company committed to transforming the treatment landscape for people suffering from GI diseases related to acid.

Investing in innovation for a healthy childhood Investing in innovation for a healthy childhood About Cure Kids Ventures Cure Kids Ventures is a seed and early stage investment fund that invests in the commercialisation of innovations in products and services with a potential to

Investment focus

Medical Device, SaaS, Medical
Seed, Pre-Seed, Series A
New Zealand

Portfolio highlights

Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.

Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.

Investment focus

Biotechnology, Health Care, Therapeutics
Series B, Series A, Series C
United States, Switzerland, United Kingdom

Portfolio highlights

Rhygaze — RhyGaze is at the forefront of developing a novel first-in-class gene therapy aimed at improving vision in patients suffering from retinal diseases.
Atalanta Therapeutics — Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases.
Alesta Therapeutics — Alesta Therapeutics pioneers innovative small molecule therapies for rare diseases, including hypophosphatasia and Charcot-Marie-Tooth

Auckland University's commercialisation arm

Investment focus

Medical Device, SaaS, Audio
Seed, Pre-Seed
New Zealand

Portfolio highlights

Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.

At ArcAngels Funding, we connect female entrepreneurs across New Zealand to venture capital and investment to help their businesses grow.

Investment focus

Medical, Genetics, Health Care
Series A
New Zealand

Portfolio highlights

Engender Technologies — Engender has developed a proprietary process to separate X (female) and Y (male) bearing bull sperm cells, enabling dairy farmers to accelerate genetic gain and improve productivity. Engender has secured scientific and laboratory facilities from one of the world’s largest AI companies in exchange for an option for it to non-exclusively licenseEngender’s technology.

Learn about Angel HQ, Wellington's Angel Investing Network - the meeting place for ambitious startups and passionate investors.

Investment focus

Software, Artificial Intelligence, SaaS
Seed, Angel, Series A
New Zealand, United States, Canada

Portfolio highlights

Hnry — Hnry automatically pays and files all taxes for contractors, freelancers, and sole traders, so they never have to think about tax again.
Cropsy Technologies — Cropsy's mission is to deliver disruptive, scalable technology to every fruit grower to unlock the full potential of their land with insights that were impossible before. Our proprietary AI-enabled hardware allows growers to monitor every plant, understand the whole crop, and track how it changes over time. These insights help growers optimiseall their decision making. The system is a simple tractor add-on, so growers do all their daily operations while Cropsy looks out for problems. Cropsy is poised to set the new gold standard for growing, with recommendations, forecasts, and providing certainty to every grower, every season.
Cetogenix — Cetogenix is a clean technology business dedicated to creating long-term solutions to global climate change.

Movac is New Zealand's most experienced technology investor and is deeply integrated into the Kiwi tech sector. We've been actively investing since 1998.

Investment focus

Software, E-Commerce, Enterprise Software
Seed, Series A, Funding Round
New Zealand, United States, Australia

Portfolio highlights

Kry10 — Kry10 is a safe operating system for SDMs.It makes the transition to an intelligent, cloud-connected, and adaptively driven future possible for automobiles, electricity grids, satellites, and medical equipment.
Miruku — Miruku is a molecular farming dairy startup developing advanced dairy proteins through plant technologies that hold the potential to produce animal-free milk proteins cost-effectively.
Re-Leased Software Company Limited — Commercial property management software that makes life easier for property managers, landlords and owners.

Investment focus

Software, Information Technology, SaaS
Seed, Series A, Pre-Seed
New Zealand, United States, China

Portfolio highlights

EarnOS — EarnOS is the fully remote company that provides Global Ad & Payments Platform powered by Web3.
Auror — The platform for retailers focused on improving safety, productivity, and profitability. Auror is used by leading Loss Prevention teams in thousands of stores.
Ivo — Ivo reduces the time, effort, and cost of negotiating agreements.

Investors by industry